Also trades as: OABIW (NASDAQ) · $vol 0M
OABI NASDAQ
OmniAb, Inc.
1W: -1.7%
1M: +0.0%
3M: +134.0%
YTD: +145.2%
1Y: +188.1%
3Y: -5.9%
5Y: -53.6%
$4.96
+0.35 (+7.59%)
After Hours: $4.75 (-0.21, -4.33%)
Weekly Expected Move ±8.8%
$4
$4
$5
$5
$5
Credit Risk of going bust: lower than 56% of companies Debt: 2.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.6%), OmniAb, Inc. would be worth roughly what it owes.
Total debt $18.9M against a stock market value of $670.2M.
Distance to default 5.73 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $9.5M (short-term plus half of long-term), stock volatility 71.9%; Altman Z'' 7.26. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.02 (down 99.6%), OmniAb, Inc. would be worth roughly what it owes.
Total debt $18.9M against a stock market value of $670.2M.
Distance to default 5.73 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $9.5M (short-term plus half of long-term), stock volatility 71.9%; Altman Z'' 7.26. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2022-03-24
Earliest Filing
2024-09-16
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named OABI in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| CNTN Tharimmune, Inc. | partner | Tharimmune has a license agreement with OmniAb to access antibody discovery technology. | 2024-09-16 | View |
| LGNZZ LIGAND PHARMACEUTICALS INC | partner | Formerly Avista Public Acquisition Corp. II (APAC), merged with Legacy OmniAb. | 2022-11-04 | View |
| OABIW Avista Public Acquisition Corp. II | acquirer | Wholly-owned subsidiary of Ligand being spun off and merged with Avista Public Acquisition Corp. II. | 2022-03-24 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-07-13 | Officer/Director Change | View | |
| 2026-06-18 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-30 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-25 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-18 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-21 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-03-18 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-07-01 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-06-21 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-03-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-11-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-11-01 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR